About: http://data.cimple.eu/news-article/ff8e103271369bd6d10bfc863f656fd54b2569a3e155d52662c3b6f3     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • France's health regulator recommended Friday that only people aged 55 and over be administered AstraZeneca's Covid-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension. The regulator said the recommendation was based on the fact that the blood clots, which prompted the vaccine's suspension in France and other European countries, had been seen only in recipients aged under 55. Otherwise, use of the vaccine in France should be resumed "without delay" after its suspension earlier this week, it said. Prime Minister Jean Castex, himself aged 55, had a jab hours later live on television in a bid to bolster public confidence in the AstraZeneca injection. "I did not feel a thing even though I am a little squeamish," the premier said at a hospital outside Paris. The European Medicines Agency (EMA) said Thursday the vaccine was "safe and effective" and "not associated with an increase in the overall risk of thromboembolic events or blood clots". But the agency added it "cannot rule out definitively" a link to a rare clotting disorder. Dominique Le Guludec, head of the French HAS health regulator, said such cases in those who had received the vaccine were "very rare" but also "serious". She said that while waiting for additional information, those under 55 should be vaccinated with the three other products approved in France: Pfizer/BioNTech, Moderna and Johnson & Johnson. As of March 16, 25 such blood clot cases have been identified in Europe, resulting in nine deaths, among people under 55 years of age, "a majority of them women", Le Guludec added. In France, out of 1.4 million AstraZeneca doses administered, cases were seen in a 51-year-old man and a 24-year-old woman, she said. The EMA's executive director, Emer Cooke, said Thursday that during its investigation, the watchdog "began to see a small number of cases of rare and unusual but very serious clotting disorder." "We still cannot rule out definitively a link between these cases and the vaccine," she said. The EMA had recommended adding a warning to product information with the AstraZeneca shot. juc-jmt-sjw/js/bp
schema:headline
  • France recommends AstraZeneca jab for over-55s only
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software